Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mpMRI for Early Evaluation of Neoadjuvant Chemotherapy in Bladder Cancer
NCT04588168Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jan 2018
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Changes from baseline tumor mp-MRI parameters at immediate mp-MRI evaluation. Started Jan 2018; status: recruiting.
Beyond the preview
Go deeper on NCT04588168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04588168.